Srinivasan Aswin, Pansuriya Tusharkumar, Wilson Branden, Sarva Siva T, Jayaram Turuvekere, Alim Salman, Kesavan Ramesh, Raza Syed
Department of Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, USA.
Department of Pulmonology/Critical Care, HCA Houston Kingwood/University of Houston College of Medicine, USA.
Case Rep Cardiol. 2021 Sep 14;2021:9986955. doi: 10.1155/2021/9986955. eCollection 2021.
Systemic inflammation-related sinus bradycardia in COVID-19 infection has not been well described yet. This six-patient case series excludes common causes of bradycardia. As bradycardia may be a sequela of COVID-19 infection, we recommend closely monitoring hemodynamics and stopping medications that can exacerbate bradycardia in these patients.
新冠病毒感染中与全身炎症相关的窦性心动过缓尚未得到充分描述。这个包含6例患者的病例系列排除了心动过缓的常见病因。由于心动过缓可能是新冠病毒感染的后遗症,我们建议密切监测这些患者的血流动力学,并停用可能加重心动过缓的药物。